PTC Therapeutics, Inc.

At PTC, we invest in our people and dedicate resources to development and learning, ensuring our employees are supported and empowered in their careers. Learn more: https://bit.ly/3LfrQVU

Our PTC team was proud to attend and participate in Parent Project Muscular Dystrophy’s 30th Annual Conference last weekend in Orlando, FL and meet those living with #Duchenne muscular dystrophy, their caregivers, leading experts and researchers, and industry partners. We continue to learn from and feel inspired by this incredible community. #PPMDeveryfuture

We are honored to receive this year's ‘Best Strategic Partnership’ award at the Life Science Industry Awards in Ireland. Thank you to our valued business partners Almac Group and World Courier for their vital role in helping us deliver innovative therapies to patients worldwide. Congratulations to all finalists and winners! #LifeScienceAwards2024 #LifeSciences #Innovation

Phenylketonuria, or PKU, is a rare, inherited metabolic disease, which affects the brain. If left untreated or poorly managed, it can cause severe and irreversible disabilities. On June 28, along with the #PKU community, we're honoring International PKU Awareness Day by sharing the facts behind some common myths about PKU. #InternationalPKUDay #PKUDay2024

We applaud the MBA students from John Hopkins Carey Business School who recently completed their Innovation Field Project, an experiential learning course that gives students an opportunity to deliver evidence-based solutions to real, complex business challenges. The students were tasked with conducting research and then presented their findings at our headquarters in New Jersey to a cross-functional team. Congratulations to all of the students on their presentation and the PTC employees who help support this project’s success! Teja Jayanthi Cristian Ramirez Loaiza, MBA Leah Svoboda, MBA Wanda Henderson Daphny M. Liz Colocho, MHRM, SHRM-SCP Mathangi Esakki, PMP, CSM Milton Velez Amee S. Nancy Pinho Mark Lingle Ann Janeski Brian Koziara Jonathan B. Elaine Yue Dong, PharmD

As we recognized Global ALS Awareness Day on June 21, PTC was grateful to the EUpALS Patient and Carer Expert Board for their valuable feedback on clinical trial design. It was a pleasure to meet the EUpALS community at the EUpALS roundtable in Sweden. #ALS #ALSAwarenessDay

It’s Global #ALSAwarenessDay. Early diagnosis can be challenging so raising awareness of this rare and fatal condition is critical.  

Today we shared interim 12-month results from the Phase 2 PIVOT-HD study of PTC518 in Huntington’s disease (HD) patients. Read more: https://bit.ly/3KO3W3T

As we continue to celebrate our 10th anniversary in Europe, we're putting a spotlight on our office and teams in Ireland. PTC’s Dublin office has been the company’s International headquarters since 2014, with highly diverse and cross-functional teams that help serve patients around the world. Learn more about our operations and the teams who are making an impact every day: https://bit.ly/3VMAjpJ #PTCEurope10

This Father's Day, we pay tribute to all caregivers who have been a vital source of love and support for their children and loved ones living with rare diseases. For John and his daughter Mia, who lives with the inherited metabolic disease #PKU, their story is one of many highlighting their determination and resilience as an inspiration to all.  #FathersDay #RareDisease #Caregivers